256393-18-7

Basic information

• Product Name: (1S,2S,5'S)-N,N-diisopropyl {2-spiro-2'-[5'-phenyl-5'-(prop-2''-enyl)-1',3'-dioxolane-4'-one]-7,7-dimethylbicyclo[2.2.1]hept-1-yl}methanesulfonamide
• Synonyms: (1S,2S,5'S)-N,N-diisopropyl {2-spiro-2'-[5'-phenyl-5'-(prop-2''-enyl)-1',3'-dioxolane-4'-one]-7,7-dimethylbicyclo[2.2.1]hept-1-yl}methanesulfonamide
• CAS NO: 256393-18-7
• Molecular Weight: 489.676
• Mol File: 256393-18-7.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: (1S,2S,5'S)-N,N-diisopropyl {2-spiro-2'-[5'-phenyl-5'-(prop-2''-enyl)-1',3'-dioxolane-4'-one]-7,7-dimethylbicyclo[2.2.1]hept-1-yl}methanesulfonamide(CAS DataBase Reference)
• NIST Chemistry Reference: (1S,2S,5'S)-N,N-diisopropyl {2-spiro-2'-[5'-phenyl-5'-(prop-2''-enyl)-1',3'-dioxolane-4'-one]-7,7-dimethylbicyclo[2.2.1]hept-1-yl}methanesulfonamide(256393-18-7)
• EPA Substance Registry System: (1S,2S,5'S)-N,N-diisopropyl {2-spiro-2'-[5'-phenyl-5'-(prop-2''-enyl)-1',3'-dioxolane-4'-one]-7,7-dimethylbicyclo[2.2.1]hept-1-yl}methanesulfonamide(256393-18-7)

Safety Data

• Hazardous Substances Data: 256393-18-7(Hazardous Substances Data)

Upstream product

• 256393-11-0 (1S,2S,5'S)-N,N-diisopropyl [2-spiro-2'-(5'-phenyl-1',3'-dioxolane-4'-one)-7,7-dimethylbicyclo[2.2.1]hept-1-yl]methanesulfonamide 
• 611-71-2 MANDELIC ACID 
• 96323-05-6 (1S)-(+)-N,N-diisopropyl-10-camphorsulfonamide 
• 256393-05-2 (1S)-N,N-diisopropyl (2,2-dimethoxy-7,7-dimethylbicyclo[2.2.1]hept-1-yl)methanesulfonamide 
• 256393-09-6 (1S,2S,5'R)-N,N-diisopropyl [2-spiro-2'-(5'-phenylmethyl-1',3'-dioxolane-4'-one)-7,7-dimethylbicyclo[2.2.1]hept-1-yl]methanesulfonamide 

Downstream Products

• 96323-05-6 (1S)-(+)-N,N-diisopropyl-10-camphorsulfonamide 
• 81037-04-9 (2S)-2-hydroxy-2-phenyl-4-pentenoic acid 

Relevant articles and documents

Process for preparing optically active α-hydroxy acids and derivatives thereof

The present invention provides a process for preparing optically active α-hydroxy acids and derivatives thereof by subjecting the alkylated 1,3-dioxolanones of formula (IV) wherein R1and R2are the same or different and are each independently H or C1-6alkyl; R5is H, C1-16alkyl, or unsubstituted or substituted phenyl; and R6is C1-8alkyl, C2-7alkenyl or unsubstituted or substituted benzyl, to either alcoholysis or hydrolysis, in which the alkylated 1,3-dioxolanones are obtained by using 10-camphorsulfonamide as a chiral auxiliary.